| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $650,010 ) |
| | 2024 | 2024 | ACADEMISCH ZIEKENHUIS LEIDEN | ALBINUSDREEF 2 | LEIDEN | | | | NLD | U01AI165745 | Baseline host and environmental factors that impact pre-erythrocytic malaria vaccine (hypo)responsiveness in endemic regions | 000 | 3 | NIH | 2/27/2024 | $585,009 |
| | 2024 | 2024 | ACADEMISCH ZIEKENHUIS LEIDEN | ALBINUSDREEF 2 | LEIDEN | | | | NLD | U01AI165745 | Baseline host and environmental factors that impact pre-erythrocytic malaria vaccine (hypo)responsiveness in endemic regions | 001 | 3 | NIH | 4/22/2024 | $65,001 |
| | 2024 | 2022 | ACADEMISCH ZIEKENHUIS LEIDEN | ALBINUSDREEF 2 | LEIDEN | | | | NLD | R01AI141315 | HLA-E restricted T-cell immunity in Mycobacterium tuberculosis infection | 000 | 4 | NIH | 3/14/2024 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $650,010 ) |
| | 2023 | 2023 | ACADEMISCH ZIEKENHUIS LEIDEN | ALBINUSDREEF 2 | LEIDEN | | | | NLD | U01AI165745 | Baseline host and environmental factors that impact pre-erythrocytic malaria vaccine (hypo)responsiveness in endemic regions | 002 | 2 | NIH | 9/15/2023 | $0 |
| | 2023 | 2023 | ACADEMISCH ZIEKENHUIS LEIDEN | ALBINUSDREEF 2 | LEIDEN | | | | NLD | U01AI165745 | Baseline host and environmental factors that impact pre-erythrocytic malaria vaccine (hypo)responsiveness in endemic regions | 001 | 2 | NIH | 3/30/2023 | $650,010 |
| | 2023 | 2022 | ACADEMISCH ZIEKENHUIS LEIDEN | ALBINUSDREEF 2 | LEIDEN | | | | NLD | U01AI165745 | Baseline host and environmental factors that impact pre-erythrocytic malaria vaccine (hypo)responsiveness in endemic regions | 000 | 1 | NIH | 3/29/2023 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $982,654 ) |
| | 2022 | 2022 | ACADEMISCH ZIEKENHUIS LEIDEN | ALBINUSDREEF 2 | LEIDEN | | | | NLD | U01AI165745 | Baseline host and environmental factors that impact pre-erythrocytic malaria vaccine (hypo)responsiveness in endemic regions | 001 | 1 | NIH | 8/31/2022 | $166,220 |
| | 2022 | 2022 | ACADEMISCH ZIEKENHUIS LEIDEN | ALBINUSDREEF 2 | LEIDEN | ZUID-HOLLAND | | | NLD | U01AI165745 | Baseline host and environmental factors that impact pre-erythrocytic malaria vaccine (hypo)responsiveness in endemic regions | 000 | 1 | NIH | 3/7/2022 | $483,790 |
| | 2022 | 2022 | ACADEMISCH ZIEKENHUIS LEIDEN | ALBINUSDREEF 2 | LEIDEN | | | | NLD | R01AI141315 | HLA-E restricted T-cell immunity in Mycobacterium tuberculosis infection | 000 | 4 | NIH | 8/30/2022 | $332,644 |
|
| Issue Date FY: 2021 ( Subtotal = $401,548 ) |
| | 2021 | 2021 | ACADEMISCH ZIEKENHUIS LEIDEN | ALBINUSDREEF 2 | LEIDEN | ZUID-HOLLAND | | | NLD | R01AI141315 | HLA-E restricted T-cell immunity in Mycobacterium tuberculosis infection | 000 | 3 | NIH | 8/19/2021 | $401,548 |
|
| Issue Date FY: 2020 ( Subtotal = $511,076 ) |
| | 2020 | 2020 | ACADEMISCH ZIEKENHUIS LEIDEN | ALBINUSDREEF 2 | LEIDEN | ZUID-HOLLAND | 2333 ZA | | NLD | R01AI141315 | HLA-E restricted T-cell immunity in Mycobacterium tuberculosis infection | 001 | 2 | NIH | 8/28/2020 | $51,155 |
| | 2020 | 2020 | ACADEMISCH ZIEKENHUIS LEIDEN | ALBINUSDREEF 2 | LEIDEN | ZUID-HOLLAND | 2333 ZA | | NLD | R01AI141315 | HLA-E restricted T-cell immunity in Mycobacterium tuberculosis infection | 000 | 2 | NIH | 8/14/2020 | $459,921 |
|
| Issue Date FY: 2019 ( Subtotal = $437,942 ) |
| | 2019 | 2019 | ACADEMISCH ZIEKENHUIS LEIDEN | ALBINUSDREEF 2 | LEIDEN | ZUID-HOLLAND | 2333 ZA | | NLD | R01AI141315 | HLA-E restricted T-cell immunity in Mycobacterium tuberculosis infection | 000 | 1 | NIH | 9/4/2019 | $437,942 |
|
| Issue Date FY: 2018 ( Subtotal = $0 ) |
| | 2018 | 2017 | ACADEMISCH ZIEKENHUIS LEIDEN | ALBINUSDREEF 2 | LEIDEN | ZUID-HOLLAND | 2333 ZA | | NLD | R21AI127133 | In depth characterization of Mtb specific HLA-E restricted human CD8+ T-cells | 000 | 2 | NIH | 9/5/2018 | $0 |
|
| Issue Date FY: 2017 ( Subtotal = $129,605 ) |
| | 2017 | 2017 | ACADEMISCH ZIEKENHUIS LEIDEN | ALBINUSDREEF 2 | LEIDEN | ZUID-HOLLAND | 2333 ZA | | NLD | R21AI127133 | In depth characterization of Mtb specific HLA-E restricted human CD8+ T-cells | 000 | 2 | NIH | 6/2/2017 | $129,605 |
|
| Issue Date FY: 2016 ( Subtotal = $159,832 ) |
| | 2016 | 2016 | ACADEMISCH ZIEKENHUIS LEIDEN | LEIDEN UNIVERSITY MEDICAL CTR | LEIDEN 2333ZA | | | | | R21AI127133 | In depth characterization of Mtb specific HLA-E restricted human CD8+ T-cells | 001 | 1 | NIH | 7/5/2016 | -$150,982 |
| | 2016 | 2016 | ACADEMISCH ZIEKENHUIS LEIDEN | LEIDEN UNIVERSITY MEDICAL CTR | LEIDEN 2333ZA | | | | NLD | R21AI127133 | In depth characterization of Mtb specific HLA-E restricted human CD8+ T-cells | 000 | 1 | NIH | 6/28/2016 | $150,982 |
| | 2016 | 2016 | ACADEMISCH ZIEKENHUIS LEIDEN | LEIDEN UNIVERSITY MEDICAL CTR | LEIDEN 2333ZA | | | | | R21AI127133 | In depth characterization of Mtb specific HLA-E restricted human CD8+ T-cells | 001 | 1 | NIH | 7/5/2016 | $150,982 |
| | 2016 | 2016 | ACADEMISCH ZIEKENHUIS LEIDEN | LEIDEN UNIVERSITY MEDICAL CTR | LEIDEN 2333ZA | | | | NLD | F32AR067050 | Epigenetic regulation in facioscapulohumeral muscular dystrophy type 2 (FSHD2) | 002 | 3 | NIH | 9/16/2016 | $1,000 |
| | 2016 | 2016 | ACADEMISCH ZIEKENHUIS LEIDEN | LEIDEN UNIVERSITY MEDICAL CTR | LEIDEN 2333ZA | | | | NLD | F32AR067050 | Epigenetic regulation in facioscapulohumeral muscular dystrophy type 2 (FSHD2) | 001 | 3 | NIH | 9/15/2016 | $7,850 |
|
| Issue Date FY: 2014 ( Subtotal = $7,850 ) |
| | 2014 | 2014 | ACADEMISCH ZIEKENHUIS LEIDEN | LEIDEN UNIVERSITY MEDICAL CTR | LEIDEN 2333ZA | | | | NLD | F32AR067050 | Epigenetic regulation in facioscapulohumeral muscular dystrophy type 2 (FSHD2) | 001 | 1 | NIH | 9/22/2014 | $7,850 |
|
|
